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Understanding Neurosurgery Through
Experimental and Computer Models
Ciro Randazzo, MD, Aditya S. Pandey, MD, Erol Veznedaroglu, MD
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Historically, the best models of human systems have been similar systems in appropriate animals.
Like human care, animal use is governed by strict laws and regulations. Violating these rules can not
only result in criminal penalties, they can also make the research worthless: an animal poorly cared
for may have physical symptoms that mask or confound the response to treatment.
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As computing power has increased, mathematical models have become more popular. The advantages
of computational models include relative costs and relative speed. No animals, drugs or equipment
have to be purchased, just a computer and software. The disadvantage is that the computational model
can only represent those aspects of the modeled system that are understood and quantifiable.
This article is an overview of how both animal and computational models have been used to approximate neurovascular conditions by researchers seeking to explore treatment options.
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Before clinical trials can begin, ethics and law demand that the ideas are tested first under experimental
models. One benefit of these pre-clinical tests is the early identification of side effects. Another is the
opportunity to practice and polish surgical technique in advance of human surgery.
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Endovascular neurosurgery is an evolving field, with the goal of treating neurological disease with
minimal invasion of the body. The current approach is to deliver focused therapies via catheters
traveling through the vascular tree. Refinement and advancement of these techniques requires not
just new ideas, but new ideas that hold up when tested through the scientific method.
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Figure 1
Canine aneurysm model

Animal Models
Aneurysm
Dog
A common animal model for aneurysms is the canine, in which aneurysms are surgically constructed
most often through the use of venous pouches. This model was first used in 1954 by German and
Black1. Shin and Niimi later revised it2 to allow the creation of four kinds of aneurysm—bifurcation,
side-wall, arterial stump and small branch, each with different hemodynamics—in one dog. The
canine models have been consistently used due to their ease of handling and anesthesia, the similarity
of the blood vessel size to that in humans, and the reproducibility of the studies. However, the canine
has a tendency toward rapid lysis of clots, which limits its validity as a model for testing thrombosis
of aneurysms after embolization3, 4
Rabbit
A rabbit model of bifurcation aneurysms has been described by Spetzger and Reul.5 Although the
rabbit has a similar blood clotting system to that of the human—an advantage missing in the dog—
this model was limited due to high rates of pneumonia, post-operative neurologic complications, and
peri- and post-operative mortality. There was also a high likelihood of inadvertent vessel occlusion
seen on angiography after creation of the aneurysms. Only about half of the procedures yielded
surgically created aneurysms which could be treated by coil embolization.
Pig
Venous pouch aneurysms have also been created on the common carotid artery in swine6 An
advantage of the swine model is that spontaneous rupture of aneurysms, like those seen in
humans, can occur7; experimental aneurysms in other animal models do not tend to rupture
spontaneously. To construct the model, an anastomosis is created between the common carotid
artery and the external jugluar vein. Retaining sutures are used to create a pouch in the proximal
draining external jugular vein. After the animal heals for one to two weeks, an endovascular
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balloon can be placed angiographically to close
the fistula, thus creating a fusiform vein pouch
aneurysm which can subsequently be used for
testing embolization devices.
Rat
Rats are popular in research for simple
economic reasons: they are cheap to purchase
and cheap to house. Many experimental
studies require a comparison of treatments
in several subjects; a large number of dogs
or pigs would be prohibitively costly, and
we have already seen that rabbits had a poor
experimental yield. In a study of twenty rats,
ten receiving Gugliemi detachable coils and
ten receiving biodegradable polyglycolide
coils8, the aneurysms were created by
permanent occlusion of the common carotid
artery (CCA) just proximal to its bifurcation,
creating an arteriotomy between the two
ligatures and directly depositing segments
of coils into the CCA. Although this model
was useful to test the response of arteries
to the deposited segments of coils, it was

Vascular

limited because the end-artery did not have
flow or anatomical characteristics similar to
aneurysms. Vein-pouch aneurysm models
have also been described in rats.9,10
Monkey
Because monkeys are so closely related to
humans, they would be considered the most
accurate model for most systems. In an effort
to more closely mimic the anatomy and
hematologic clotting characteristics of the
human, Tenjin and Ueda developed a primate
aneurysm model.11 They used femoral vein
pouches to create venous pouch aneurysms
bilaterally on the carotid arteries of Japanese
monkeys. They noted a success rate of 74% at
two weeks in creating their aneurysms.
Arteriovenous Malformations (AVMs)
Pig
Pig vessels approximate the size of human
vessels, their coagulation profile is similar to
that in the human and they are fairly simple
to anaesthetize. With these advantages, the
pig model is the most commonly used and
described model of cerebral AVMs. The swine,
and other mammals including sheep, goat, ox
and cat, provide blood supply to the brain via
an arterial network of vessels, known as the rete
mirabile, which is surrounded by the cavernous
sinus at the base of the brain. Because the rete
mirabile is a purely arterial network (as seen
in other mammals including sheep, goat, ox
and cat), a valid AVM model is created as
an arterio-venous fistula formed by isolating
and anastomosing the external jugular vein
and common carotid artery on one side of the
neck.3,4 The creation of this fistula with occlusion
Arterial network
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of carotid artery branches has been shown to
increase flow and pressures across the rete12-14
and result in histologic changes to vessel walls
very similar to those seen in human cerebral
AVMs.15 This model has been used repeatedly
for training in endovascular techniques, to
evaluate nascent embolic materials and for
histologic evaluations of radiosurgical induced
changes.16,17

to allow blood to escape and thus induce
vasospasm. Some of these models involve open
cranial surgery to puncture the vessels, while
others have implemented perforating the vessel
from the luminal side by using an endovascular
approach. They also describe extracranial
models of vasospasm although they do point
out that these models are controversial because
their validity is questionable.

Dog
The only canine AVM model described is also
the only completely intracerebral AVM model.
Pietilä et al.18 created an arteriovenous fistula
(AVF) by interposing a segment of superficial
temporal artery between a main branch of the
middle cerebral artery and the sagittal sinus.
They concurrently implanted a muscle graft
supplied by a branch of the fistula onto the
ischemic area of the brain. Their intent was to
have the ischemia serve as an angiogenic stimulus and thus mimic the angiogenesis that occurs
in human AVMs. The authors found that many
other aspects of this model mimicked human
AVMs, including: thickening and fibrosis of
the wall of the draining vein; angiogenesis surrounding the area of the created AVM with
new vessels demonstrating pathological wall
changes; gliotic brain tissue formation and
areas of ischemia; hemorrhage and thrombus
formation in the brain tissue and vessels surrounding the created nidus. The authors did
not however, report any attempts at experimental treatments of this model.

Simulations

Rat
In the rat, Bederson19 created an extracranial
arteriovenous fistula with occlusion of the
contralateral vein. This was first created in an
attempt to determine if a dural AVM would
form as a result of sinus thrombosis. This model
has been further modified to evaluate cerebral
hypoperfusion20, the role of radiotherapy in
the treatment of AVFs/AVMs21, and the role
of sinus hypertension and thrombosis in the
development of dural AVMs.22
Vasospasm
Cerebral vasospasm continues to be one
of the major causes of morbidity and
mortality following anuerysmal subarachnoid
hemorrhage. Megyesi et al. published a review
of fifty-seven in vivo animal models of cerebral
vasospasm dating back to 1928.23 These models
employed rats, rabbits, cats, pigs, canines and
primates. 72% used a technique in which blood
was instilled around blood vessels to cause
vasospasm and the remainder used a technique
whereby they punctured or lacerated a vessel

Aneurysm
In a joint project between the departments
of Neurosurgery and Aerospace Engineering,
Kim et al.24 used a computational fluid
dynamics software package to assess the risk
of aneurysm rupture when porous stents were
used as the sole treatment. Such models are
reliable to the point where they can predict
angiograms.25 A model of a wide-necked basilar
trunk aneurysm was constructed based on the
patient’s CT scans. The aneurysm was modeled
untreated and treated with 1-3 stents from
various manufacturers. The model predicted
that these stents could suppress complex blood
flow associated with ruptured aneurysms in
another simulation study26, although the size
of the effect depended on the specific geometry
and on how well the stents were deployed and
that a single stent would probably be insufficient
to ensure a good outcome.
Arteriovenous Malformations (AVMs)
Hademenos and Massoud created a
mathematical model based on electrical
networks.27, 28 This model was designed
to allow an analysis of changes in AVM
hemodynamic and biophysical characteristics,
and individual parameters could be
manipulated to determine changes in flow
characteristic and likelihood of rupture or
hemorrhage after various treatments.
Kerber and Hecht29 implemented on a
personal computer (with an Intel 286
microprocessor!) a mathematical model which
represented the AVM as a collection of 1000
channels, each of which must be embolized
to “cure” the simulated AVM. They later30
constructed a physical model from a sponge
with waxed tubes representing inflow (arterial
feeders) and outflow tracts (draining veins).
These models were intended to help guide
the development of new neurointerventional
techniques. The physical model made it further
possible to test liquid embolic materials using
microcatheters, and to teach endovascular
embolization techniques in a no-risk situation.
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Applications in Training
In an ongoing effort to promote patient safety
and enhance skills training, recent advances in
technology have contributed to the development
of non-animal simulation technology. These
simulators enhance learning fundamental skills
in procedures such as basic suturing, laparscopic
surgery and endovascular treatments. As the
technologies improve, the fidelity of these
models has improved the reliability of these
systems. For example, Wong et al.31 describe
a 3D virtual reality system integrated with
simulated manipulators for training in
craniotomies and aneurysm clipping. A variety
of clips and patient aneurysms were scanned
into the simulator database so the user could
learn how and why to combine different clips
with different surgical approaches. Another
group32,33 used the same system to train clinicians
in minimally invasive surgical techniques.
The development of haptic technologies, which
provide touch and pressure feedback, have
significantly improved the tactile experience
of simulators.34, 35 Currently in use at the
Jefferson Hospital for Neuroscience (JHN)
is the Procedicus VIST™ simulator. This is a
virtual reality simulator system that uses haptic
feedback and metric assessment.36, 37 It can be
used to acquire and hone basic and complex
neuroendovascular skills. The system utilizes
a mannequin and two computer screens
along with actual endovascular equipment.
The computer allows the user to choose from
a variety of different programs representing
different pathologies, e.g. saccular aneurysms,
fusiform aneurysms, carotid stenosis.
The simulator at JHN has been used by
neurointerventional technologists, residents
and fellows to develop proficiency in various
procedures. This leads to increased benefits
for practitioners, as they have improved skills
and confidence when performing procedures
on patients. The simulator has also improved
patient safety as simulators have been shown
to improve performance in endovascular
procedures.38

Conclusion
The new era of evidence-based management
of disease will continue to demand increased
justification from physicians for the treatments
they use. At the same time, ethical constraints
limit the early testing of new technologies on
patients. Animal models, when designed,
validated and used appropriately, can be an
invaluable resource in the development of lifesaving technologies and techniques.
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One reason to model a biological system is
that construction of the model proves enough
understanding to reproduce the system. It is
presumably that same understanding that makes
neurosurgical repair of the patient possible. A
potential advantage of computational models
is the opportunity to perform many virtual
experiments in less time than it would take to
perform one real experiment, but this depends
on the power of the computer relative to the
complexity of the model. An extension of this is
using a computer to design optimized surgical
plans and project the likely outcomes for patients
in advance of surgery. The potential of computer
models is restricted by the bottom limit of our
ability to observe physiological processes and
represent them on computer: as yet, we may not
even have approached that limit.
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Spinal/Functional

Spinal Cord Stimulation
for Control of Pain
Stephen Falowski, MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania

Introduction
Spinal cord stimulation (SCS) is an adjustable, non-destructive procedure which delivers therapeutic
doses of electrical current to the spinal cord for the management of neuropathic pain. The most
common indications include post-laminectomy (“failed back surgery”) syndrome, complex regional
pain syndrome (CRPS), ischemic limb pain, and angina. Other reported applications include
visceral/abdominal pain, cervical neuritis pain, spinal cord injury pain, post-herpetic neuralgia, and
neurogenic thoracic outlet syndrome.

History
Advances in technology have driven the popularity of the field. Initially, the contact combinations
could only be hardwired, and could not be reprogrammed after the pulse generator was implanted.
In the beginning, only radio-frequency (RF) driven passive receivers were available. In the midseventies, the first implantable pulse generator powered by a lithium battery was introduced into the
market. In 1980, the first percutaneous electrode was produced, and this could be reprogrammed
non-invasively through an external transmitter.1

Mechanisms of Action
SCS began when Melzack and Wall2 noted that stimulation of large peripheral nerve fibers could
block the sensation of pain. In 1967, Shealy3 inserted the first dorsal column stimulator in a
human suffering from terminal metastatic cancer. Later approaches implanted electrodes via a
laminectomy in the subarachnoid space, between the two layers of the dura, or in the epidural
space.4-6 Subsequently, less invasive percutaneous techniques were introduced.7
The exact mechanisms of action of SCS remain unclear, although computer modeling work has
shed some light on the distribution of complex electrical fields within the spine.8-13 Animal studies
suggest that the SCS triggers the release of serotonin, substance P, and GABA within the dorsal
horn.14, 15 It is not known whether stimulation of different sites—peripheral nerves, dorsal columns,
or supra-lemniscal pathways—will trigger equivalent mechanisms of action.

Indications
SCS has been successfully used for a variety of pain conditions (Table I). Experience suggests that,
in selected patients, SCS can produce at least 50% pain relief in 50-60% of the implanted patients.
Interestingly, with the proper follow-up care, these results can be maintained over several years.
Complex Regional Pain Syndrome (CRPS)
The implementation of SCS in individuals with CRPS type I is more difficult than with any other
patients groups. There is risk of aggravating the original pain or causing a new pain at the implanted
hardware site is greater than with any other diagnostic category mentioned. The CPRS-affected areas
may be too widespread for effective stimulation.

In 1989, Barolat et al. reported reduction of pain in ten out of thirteen patients implanted. No patients

in that series were made pain free but all ten reported a definite difference from stimulation.16 In 1997,
Kumar et al. reported on twelve patients with permanently implanted leads17: eight patients enjoyed
near complete resolution of their symptoms and four also maintained good relief.
Kemler et al. reported 23 additional cases with 78% of the patients reporting improvement.18 A later
study19 compared patients randomized to SCS to those treated with physical therapy. In the SCS
group, 67% of patients experienced significant pain relief which persisted at 6 months. However,
no functional improvement was observed in either group. A 5-year follow-up on the SCS group
indicated that the effects of SCS diminished over time for these patients.20

Oakley and Weiner reported a prospective
study of 19 patients with CRPS implanted with
spinal cord stimulation systems.21 Of the ten
patients in whom detailed long-term efficacy
data was available, three reported full relief
from their pain and seven, partial beneficial
relief.
Three additional prospective studies without
matched controls have been reported.21-23
Two of the studies reported success rates
with an 84% overall success rate. The third
study by Calvillo et al.22 reported a significant
improvement in pain scores and a >50%
reduction in narcotic use by 44% of subjects. In
eight retrospective studies the overall success
rate was 84% 192 patients.24
Post-laminectomy syndrome aka
Failed back surgery syndrome (FBSS)
Post-laminectomy syndrome is a broad term
which can include pain localized to the lower
lumbar region or the buttocks, persistent
radicular pain, or diffuse lower extremity pain.
Most published series distinguish between
back and leg pain, but seldom define the
details of the pain syndromes. SCS is accepted
in the treatment of leg pain, but its widespread
use for relief of pain in the lower lumbar area
still remains to be defined.
A technical challenge has been to provide
stimulation in the low back, where paresthesia
is often replaced over time by an unpleasant
segmental band of stimulation from the
thoracic roots. Previous pioneering work
by Jay Law25, 26 has shown that stimulation
in the low back can be obtained only if one
uses multiple arrays of closely spaced bipolar
electrodes at T9-T10. North et al. have shown
that one single quadripolar electrode in
midline has the ability to stimulate the axial
low back.27 Flanking the cathode by lateral
anodes also appears to increase the discomfort
threshold theoretically.28
Marchand et al.29 conducted a prospective
randomized controlled study examining patients
with at least one prior surgery for chronic back
pain secondary to trauma. Each patient used
a SCS and acted as his or her own control.
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Although a small trial, with only eight patients,
pain scores were significantly reduced with SCS
compared to placebo stimulation.
The longitudinal studies by North showed
that in patients with post-surgical lumbar
arachnoid or epidural fibrosis without
surgically remediable lesions, SCS provided at
least 50% pain relief in 53% of patients at 2.2
years.30 North et al. also conducted a study
randomizing patients with FBSS to either
repeat back surgery or SCS surgery,33 allowing
crossover after six months. Ten of fifteen
patients crossed over from back surgery
to SCS, while only two of twelve patients
crossed over from SCS to back surgery.
Turner et al.31 systematically reviewed a total
of 41 articles from 1966 to 1994 and noted
that approximately 50-60% of patients with
post-laminectomy greater than 50% pain relief
was attained from the use of SCS. In 1996,
Burchiel et al. conducted a prospective multicenter study with one year follow-up and also
reported 55% successful stimulation.32

Angina
There are well documented reports in the
literature revealing uniformly good results
using SCS to relieve anginal pain.34-38 Further,
the results have been maintained in long term
follow-up and have been substantiated by
a reduction in the intake of nitrates as well.
Interestingly, other findings have supported
the evidence that SCS has effects that go
beyond pain relief. The observations that
there is less ST segment depression and that
the exercise capacity, the time to angina and
the recovery time all improve with stimulation
may suggest that there is a reduction in
ischemia. In a positron emission tomography
study, a redistribution of myocardial flow in
favor of ischemic parts of the myocardium
has been demonstrated as a long term effect of
spinal cord stimulation, both at rest and after
pharmacologic stress induction.39
Vulink et al. conducted a prospective study
on quality of life changes in patients with
refractory angina pectoris implanted with SCS.
They found that both the pain and the health
aspects of quality of life improved significantly
after 3 months of SCS. Further, social, mental
and physical aspects of quality of life were
found improved after one year of SCS.40
Hautvast et al.41 implanted SCS in patients with
stable angina pectoris and randomized them.
One group’s remained inactivated while the
other group was instructed to use the stimulator
three times per day for one hour and with any
angina attack. At 6 weeks, compared with
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controls, the treatment group had increased
exercise duration and time to angina, and
decreased anginal attacks and sublingual nitrate
consumption. Also, observed was a decrease
in ischemic episodes on EKG, as well as a
decrease in observed ST segment depressions
on exercise EKG. There was an increase in
perceived quality of life and decrease in pain.
Mannheimer et al.42 randomized 104 patients
accepted for CABG to receive either CABG
(n=51) or SCS (n=53) in the ESBY study.
This study demonstrated that patients
randomized to SCS showed a greater than
30% improvement in Nottingham Health
Profile (NHP) scores compared with baseline,
which was significant and comparable to the
improvement shown by patients randomized
to CABG.43 These results were consistent on
follow up after four years. It is important to
know that the five-year mortality of 27.9%
in the ESBY study was similar between those
receiving SCS and those who received CABG,
with no difference in the percentage of cardiac
deaths. The ESBY study showed that cardiac
events were similar across the groups, but that
there was significantly more cerebrovascular
events observed in the CABG group.
Both groups experienced a significant
reduction in both the number of angina attacks
and the consumption of nitrates. There was
no significant intergroup difference regarding
these parameters. In another prospective
study of 104 patients who underwent SCS
implantation for refractory angina pectoris
there was a significant decrease in angina
episodes at rest, angina episodes with activity,
and total angina episodes 44
DeJongste et al.36 randomized seventeen
patients with angina to an active treatment
group (i.e. SCS implantation) and a control
group. The control group was followed for
two months followed by SCS implantation.
Both groups were followed for a total of 12
months. This study also revealed a statistically
significant reduction in the incidence of angina
attacks and in the consumption of nitrates.
Five additional studies are reported to be prospective but without matched controls.36, 40, 45-48
Each of these revealed significant benefit from
spinal cord stimulation. The benefit indices
ranged from reduction in angina attacks,
decrease nitrate consumption, decrease in
NYHA grade and improvement in NHP grade.
Andersen et al. reported that out of 45 patients
treated with SCS for anginal pain, there were
three who had also survived a myocardial
infarction49: all three patients noticed the pain

to be different and unrelieved with SCS and
all patients correctly guessed that the pain was
due to a myocardial infarction. The authors
concluded that SCS reduces the severity of
anginal attack, but was unable to suppress the
conduction and perception of cardiac pain
signals which act as alarm signals of cardiac
distress. Similarly, Murray et al. have shown
that SCS for refractory angina is effective
in preventing hospital admissions without
masking the ischemic symptoms or leading to
silent infarction.50
How SCS reduces angina is unclear.
Hautvast et al.41 demonstrated no significant
changes in heart rate variability after 6 wks,
concluding that autonomic modulation of
heart rate may not be the mechanism of
action. There SCS may reduces myocardial
ischemia via homogenization of myocardial
blood perfusion.39,51 SCS can improve lactate
metabolism in the heart muscle, and lactate
metabolism, oxygen demand and blood
flow in the coronary sinus.52 SCS does not
effect variability in heart rates or cardiac
arrhythmias.35, 53, 54
We do not know whether the pain relief is
due to direct depression of the nociceptive
signals in the spinal cord or whether there
is secondary gain from a reduction in the
ischemia.55,56 Foreman has shown that
dorsal column stimulation inhibits the
activity of spinothalamic tracts cells evoked
by activation of the cardiac sympathetic
afferents or by intracardiac bradykinin.14
On the other hand the stimulation might
producing a prolonged inhibition of the
hyperactive sympathetic system, as was shown
experimentally in the rat by Linderoth et al.15
The most appropriate electrode location for
the treatment of angina pectoris is most likely
the lower cervical and upper thoracic region,
although some have reported successful higher
cervical placements.42 Another consideration
is continuous versus cyclical use of SCS. In
practice, patients using SCS for angina pectoris
often use a low intensity stimulation for several
hours per day for prophylactic purposes.57
Recently, a randomized control study
demonstrated improvement in functional
status and symptoms in treatment arms with
conventional or sub threshold stimulation
in comparison to a low output placebo
treatment arm.58

Abdominal/Visceral Pain
Syndromes
Approximately 20% of the population in
United States have abdominal pain. There are
many etiologies for abdominal pain including
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gastrointestinal, genitourinary, musuloskeletal
and nervous systems. Treatment modalities
have included cognitive- behavioral, physical,
and pharmacological therapies. Other more
invasive therapies have extended to include
celiac plexus blocks and celiac ganglia
destruction. Some studies have demonstrated
some localization in the spinal cord for visceral
pain secondary to malignancy. Midline
myelotomy through the dorsal columns at
the level of T10 has shown success in eight
patients with refractory pelvic cancer pain.
This was also demonstrated in animal studies
where dorsal column activity was observed in
pelvic visceral nociception.59
Several studies have demonstrated the benefit
of SCS in abdominal visceral disease. Ceballos
et al.60 demonstrated reduction in pain scores
and decrease in narcotic use in a patient treated
for mesenteric ischemia. Krames et al.61
described a patient treated for irritable bowel
syndrome who was developing escalating pain
and diarrhea. In the first 6 months there was
a subjective decrease in pain on a 10-point
scale from 9/10 to 2/10, with only two diarrhea
episodes and with significant reduction in pain
medications. There was some return of pain
after ten month follow-up, but still a significant
reduction in diarrhea. Khan et al.62 reported
on the largest series with nine patients with
refractory abdominal pain, all of whom had a
significant improvement in pain scores as well
as decreased narcotic use at six to eight month
follow up.
Tiede et al. described treatment of refractory
abdominal pain in two patients. Both patients
had a significant history including multiple
abdominal surgeries and failed conservative
measures. Each patient had an element of
postprandial abdominal pain with associated
nausea and vomiting. In both patients the leads
were placed at the T2 level with significant
improvement in pain, decreased narcotic use
and increase functioning, such as return to
work63. Kapur et al.64 recently described relief
of abdominal pain associated with colchicine
intolerant or resistant patients with familial
Mediterranean fever by placement of the
electrodes at the lower thoracic levels.
More recent studies have looked at the
treatment of visceral pelvic pain with
reference to the dorsal columns and spinal
cord stimulation. Kapural et al.65 reported
on the value of neurostimulation for chronic
visceral pelvic pain in six female patients with
the diagnosis of long-standing pelvic pain.
These patients had a history of endometriosis,

multiple surgical explorations, and dyspareunia.
At an average follow up of 30 months there was
a significant decrease in the pain score with an
average of more than 50% pain relief, with a
decrease in opiate use.
Visceral innervation follows the embryologic origin and location of the viscera and is
arranged in viscerotomes, analogous to cutaneous dermatomes.66 The viscera obtain their
innervation via the sympathetic and parasympathetic pathways. The parasympathetics carry
their afferents to anterior and posterior vagal
trunks and are therefore not as amendable
to spinal cord stimulation. The sympathetics
carry nociceptive information from the viscera
to spinal nerve roots making them a more
viable target. The sympathetic afferents in the
lower six thoracic and the upper three lumbar
spinal segments have been shown to transmit
painful impulses from the viscera 67.

Equipment (Electrodes and
pulse generators)

There are various implantable technologies

existing for SCS. These include trial percutaneous electrodes, permanent percutaneous

electrodes, permanent plate electrodes, totally
implantable rechargeable and non-rechargeable pulse generators (IPG) and radiofrequency
(RF) driven pulse generators.
Percutaneous electrodes
Percutaneous electrodes can be inserted without
much dissection and can easily be removed
in the implanting physician’s office. During
implantation, these electrodes can be advanced
over several segments in the epidural space,
allowing testing of several spinal cord levels to
assess for optimal electrode position.
Contemporary percutaneous electrodes are
slim electrodes, only a few millimeters in
diameter and containing four or eight contacts
(referred to as either quadripolar or octopolar
electrodes). Choosing the particular electrode
entails deciding how many segments of the spinal cord are to be covered, with larger spacing
allowing broader coverage. Alternatively, closer
spacing allows better steering and electric field
shaping. Additionally, multiple parallel electrodes and different configuration matrices
can be constructed which can create extremely
focused electrical fields.

Figure 2
The above graphic on the left shows a patient who had an L4,5 and L5,S1 anterior posterior
fusion for back and leg pain from lumbar spondylolisthesis. She continued to have
both back and leg pain despite a successful lumbar reconstruction. An ANS (Advanced
Neuromodulation System) tripole electrode was implanted in the thoracic spine. There are
three columns of electrodes. The middle covers the back and the lateral columns provide
stimulation into the legs. The electrode was placed in the operating room with fluoroscopy
and intra-operative EMG monitoring under general anesthesia.
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Plate electrodes
Plate-type electrodes (or ribbon electrodes,
paddle electrodes, or laminotomy electrodes)
require a surgical procedure, laminotomy, and
implantation under direct vision. Implantation
under direct vision may be safer in the upper
thoracic and cervical areas, where there is
a risk of damaging the spinal cord with the
large bore Touhy needle. Most implants can
be done through a skin incision between 2.5
cm and 4 cm long, depending on the size of
the patient and spinal anatomy. The amount
of bony removal is usually minimal.
The main advantage of plate electrodes is
their greater inherent stability, with less to
migrate. Plate electrodes are also more energy
efficient. Multiple arrays or different electrode
configurations can be constructed with plate
electrodes. As with percutaneous leads, there
are varying lengths, and shapes—such as
curved leads and hinged leads, all designed to
help facilitate insertion and tailor the electrode
selection to the patient. They are a preferred
option in the case of previous spine surgery at
the implant levels.
North et al. have published on comparison
between plate and percutaneous electrodes.68
Laminectomy electrode placement, although
more invasive than percutaneous placement,
yielded significantly better clinical results in
patients with failed back surgery syndrome
at up to 3-year follow up. Clinical success was
defined as at least 50% pain relief and patient
satisfaction with treatment. Secondary outcome
measures were ability to perform various
activities of daily living, neurological function,
and analgesic use. There is some theoretical
evidence that shaping of the electrical field is
possible with even more complex electrode
arrays. Holsheimer et al.69 concluded that the
transverse tripolar system enabled finer control
of paresthesia. Electrical field steering could
change the paresthesia area completely. Using
transverse tripolar configurations increases
the threshold for stimulation of dorsal roots.
This results in a wider therapeutic range, wider
paresthesia coverage, and a greater probability
to fully cover the painful area with paresthesia.
Rechargeable and Non-rechargeable
Pulse Generators and RadioFrequency Receivers
Electrical stimulation consists of rectangular
pulses delivered to the epidural space through
implanted electrode via a power source. Two
basic types of systems are currently available:
an Internal Pulse Generator (IPG; also
called the battery) or a radiofrequency (RF)
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coupled pulse generator with an implantable
receiver. The later has largely fallen out of
favor due to the inconveniences of having an
external power source. However, the advent
of the totally implantable, rechargeable
pulse generator has surmounted the power
requirement issues, which were previously the
main RF advantage.
The totally implantable pulse generator
contains a lithium battery. Activation
and control occur through an external
transcutaneous telemetry device. The IPG
can be turned on and off through a small
controller which the patient can carry. The
controller also allows some control over
the stimulation parameters. More extensive
control of the unit can be achieved through a
small portable unit which can be programmed
by the physician. Life span of the battery varies
with usage and with the utilized parameters
(voltage, rate, pulse width, etc.). Most patients
can expect that the battery will last from 2.5
to 4.5 years. Available lithium powered pulse
generators allow stimulation with fine control
of stimulation amplitude, pulse width and
rate. Replacement of the battery requires a
surgical procedure which is usually performed
on an outpatient basis.
Radio frequency (RF) driven systems,
consist of a passive receiver, implanted
subcutaneously, and a transmitter which is
worn externally. An antenna applied to the
skin in correspondence of the receiver is
connected to the transmitter, which sends
the stimulation signals transcutaneously. RF
systems have the inconvenience of having
to wear the antenna and the radio-receiver,
replacing the batteries on a regular basis,
and ensuring proper contact of the antenna
on the skin. These issues may be critical
for individuals with limited upper-limb
motor function. Other patients, particularly
individuals who have reflex sympathetic
dystrophy (RSD), may not tolerate the antenna
taped to the skin. However, what one loses in
convenience, however, is gained in power
and flexibility. Currently only RF systems
can provide a stimulation rate up to 1,400
Hz. This might be beneficial in some patients
with neuropathic chronic pain syndromes70
as well as in patients with extrapyramidal
motor disorders.

inherent in any spine surgery. Infection of
the implanted hardware has occurred with
a 3-5% rate. Persistent pain at the implant
site has been seen in about 5% of patients.
Recalcitrant cerebrospinal fluid leakage has
been encountered in a few patients, requiring
multiple surgical revisions. Breakage or
malfunction of the implanted hardware,
particularly the electrodes and the subcutaneous
extension cables has been encountered in
about 10% of the implanted systems. Painful
stimulation, necessitating either repositioning
or removal of the electrode, has also been
reported in a number of cases.

Conclusions
The treatment of chronic pain remains
challenging. Spinal cord stimulation has been
performed for over 30 years, and slow but
steady progress with this technology has been
made. As the equipment and stimulation
parameters are improved, selection criteria
have been better defined and are slowly being
expanded. More importantly, experience in
the technique and the equipment has made
SCS a much more reliable and safe modality.
Like all the modalities performed for chronic
pain management, its results are favorable.
It is important to remember that the goal of
neurostimulation is to reduce pain, rather than
to eliminate pain. It has been shown to have a
50% improvement in pain relief, and reduce
the use of more medications Very few other
invasive modalities can claim this success rate
with a few years of follow-up.
Careful follow-up of the patients is necessary for
successful long-term satisfaction. Equipment
related problems can arise at any time after
implantation, such as discomfort at the
pulse generator/radio receiver site, electrode
breakage or migration, infection, etc., and an
open dialogue with the patients is vital for the
continuing successful implementation of the
modality. Spinal cord stimulation has earned a
well established and firm role in contemporary
chronic pain management.
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Primary Stroke Centers: Their Role and
Impact on Acute Stroke Management
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The management of acute ischemic stroke has been recognized as a significant medical problem.
Stroke remains to be the third leading cause of death and the leading cause of long-term disability;
80% of all strokes are ischemic (a blood clot disrupts blood flow), and the rest are hemorrhagic
(a blood vessel ruptures in the brain). Nearly 1 in 15 deaths in 2003 were the result of a stroke.1
Approximately 750,000 new strokes occur annually, of which 250,000 result in the deaths in the
United States alone. The latest estimates for stroke costs total to about $30 billion in direct costs,
and $20 billion are in indirect costs.2 If nothing is done about this disease, the annual incidence of
strokes is expected to reach 1.1 million by the year 2015.
Despite recent advances in its diagnosis and treatment, a population of the general public still have
difficulty recognizing stroke symptoms, and are unaware that stroke is indeed a medical emergency.3
The two major causes of delay in treatment are mainly failure to appropriately recognize the
symptoms that indicate stroke (numbness, dizziness, confusion, or headache), and failure to access a
medical facility that is equipped to handle acute strokes. In an effort to raise awareness, and the level
of care provided to stroke patients, stroke center standards were created and hospitals that met the
strict criteria were then selected. However, many hospitals do not have the necessary infrastructure
and organization needed to triage and treat patients with stroke rapidly and efficiently.4
Seeing that the model of trauma centers were effective both in the rural and urban settings,
the concept of acute stroke centers were then explored. The Brain Attack Coalition, which is a
multidisciplinary group involved in stroke care, set out to establish guidelines for stroke centers.
The role of a Primary Stroke Center is to be able to stabilize and provide emergency care for the
acute stroke patients. Depending on the complexity of the case, they would either admit the
patient, or transfer them to a comprehensive stroke center. On the other hand, the Comprehensive
Stroke Center should be able to provide complete care to any complex patient; they should have
the necessary infrastructure, both in personnel and equipment.
The main goals and benefits of a certified stroke center are the following:
• Improve the efficiency of patient care
• Provide access to the most up to date stroke therapies, which ultimately will lead to fewer
peristroke complications
• Increase the number of patients discharged home than to skilled nursing facilities
• Decrease the length of hospital stay.
By accomplishing all of the above, the cost to the healthcare system will be reduced, and hopefully,
patient satisfaction should also increase.
Although advances in stroke treatment have moved forward over the past years, the main limitation
remains to be the prompt and proper treatment. Thrombolytic therapy, which has been FDA
approved for over 10 years now remains to be the mainstay of acute treatment, however, only about
3% of patients with acute strokes are being treated. Another important goal of stroke centers is to
provide access to these acute therapies.
The Brain Attack Coalition and American Stroke association have developed a framework of
requirements needed to establish a Primary Stroke Center. These elements are based on the use
of standardized method of delivering evidence based clinical care with known improvement of
patient outcome. The Joint Commission has recognized the effectiveness of these measures and
has based their criteria for Primary Stroke Center Certification on the recommendations listed in
the accompanying table.6-8
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Drs. Erol Veznedaroglu
(Neurosurgery) and Carissa
Pineda (Neurology) with the Gold
and Silver Performance Awards from
the American Heart Association for
maintained high standards in care and
management of stroke patients.

In this decade, the integration of
multidisciplinary approach in the treatment
of strokes will occur within the structure of
a stroke center. Establishing a Stroke Center
requires coordination of efforts throughout
the Health System. Even hospitals with limited
resources can positively impact the outcome
of a stroke patient. Smaller healthcare centers
can develop a “Stroke Network” with larger
healthcare centers to provide comprehensive
care. The most crucial component of stroke
care is time—“Lost time equals lost brain” is the
slogan, as brain damage progresses the blood
flow is cut off. Rapid evaluation and referral
with “Treat and Transfer” protocols can be
established at any hospital that has the ability
to provide Emergency Services. With new
therapies emerging for stroke treatment, this
could significantly impact all patients having
access to cutting edge stroke care.
The American Heart Association’s Performance
Awards for hospitals is based on 85%
compliance for patients in each of the following

Vascular

items. The Silver Award is given to institutions
who meet goals for 12 months and the Gold
Award, for 24 months.

• Percent of ischemic stroke or TIA patients
discharged on antithrombotics (e.g., warfarin,
aspirin, other antiplatelet drug)

•P
 ercent of acute ischemic stroke patients
who arrive at the ED within 120 minutes
(two hours) of onset of stroke symptoms
who receive IV t-PA within 180 minutes
(three hours) of onset of stroke symptoms

• Percent of ischemic stroke or TIA patients
with atrial fibrillation who are discharged on
anticoagulation therapy (warfarin/Coumadin
or heparin/heparinoids) unless an absolute or
relative contraindication exists

• Percent of ischemic stroke or TIA patients who
receive antithrombotic medication within 48
hours of hospitalization

• P ercent of patients at risk for DVT who
received DVT prophylaxis by the second
hospital day

• Percent of ischemic stroke or TIA patients
with LDL >= 100 mg/dL OR on cholesterol
reducer prior to admission who are discharged
on cholesterol reducing drugs
• Percent of smokers who receive smoking
cessation advice or medication (e.g.,
Nicoderm or Zyban) at discharge
These steps are all based on published
evidence assessing modifiable risk factors
which affect the likelihood of stroke.9, 10
Any one of these risk factors can double the
chance of a stroke recurring.

Acute Stroke Team

Neuroimaging

This is composed of physicians and health care professionals with experience and proper training
in management of acute strokes. They should be available 24 hrs a day to evaluate patients with
symptoms suggestive of an acute stroke. The institution should have a Stroke notification system
in place with documented expected response times.

In order to have a proper stroke diagnosis,
it is vital for a primary stroke center to have
imaging capability 24 hours a day. The ideal
door to imaging time is within 25 minutes
of order entry, and must be interpreted
within 20 minutes.

Written Care Protocols

One of the major key elements in developing good outcomes is through the implementation of
protocols. As such, protocols should be based on well established Standards of Care and national
guidelines. This should include emergency care of ischemic/hemorrhagic stroke patients. Studies
have shown that by adhering to protocol guidelines, more patients were properly screened for
tPA. Not only was there a substantial increase in the proportion of patients receiving thrombolytic
therapy, but rather, there was also a decrease in the rates of symptomatic ICH.5 If the patient is
deemed to be complex, a protocol should be in place for those requiring transfers to a comprehensive
center—a “Treat and Transfer” pathway should be initiated.
Emergency Department

The ED serves as the gateway between the patient and the hospital. It is important that emergency
personnel are trained in recognizing, diagnosing, and treating all types of acute stroke. There should
be highly organized means communication amongst the EMS, ED personnel and the Acute Stroke
Team. The ED should be able to provide proper documentation of patient’s history, procedures, and
qualifications for thrombolytic therapy.
Stroke Unit

This is a dedicated unit staffed by health care personnel (vascular neurologists, stroke-trained
nurses, physical/occupational/speech therapists, case managers, social workers) who are trained to
care for patients with cerebrovascular diseases. This unit should also be equipped with infrastructure
such as continuous telemetry, and the capability for blood pressure monitoring. There has been a
big difference noted in the care received by stroke patients in the stroke unit setting as compared
to the general medical floors. Patients in stroke units had an 8% reduction in length of stay, and 7%
increase in going back to living at home, and a 17% reduction in death rates. The cost of forming
and operating stroke units will vary depending on size and location. Again, there is a need for
written care protocols for standardization of care.
Neurosurgery

During the acute phase of a stroke, patients may need a neurosurgical procedure, thus, a primary
stroke center must be able to provide neurosurgical care within 2 hours if clinically necessary. If this
is not met, the patient should be transferred to a medical facility with an available neurosurgeon
who is experienced in treating different types of acute strokes. A protocol is necessary to Treat and
Transfer patients with the need for comprehensive stroke care.

Hospital and Administrative Support

There should be a designated Medical
Director of Stroke Center with expertise
and training in Cerebovascular Diseases.
Com mit ment f rom ad mi nist rat ion of
hospital/health system is important in
providing support and funding for the
needed resources to maintain the ability
to deliver high quality and efficient care to
acute stroke patients and the community.
Laboratory Services

This should be available 24 hrs. a day (CBC,
Chemistry and Coagulation studies) The
chest x-ray and EKG must be completed
within 45 minutes of patient’s arrival
Outcome/Performance Improvement:

Primary Stroke Centers must be able to develop
specific stroke performance measures to be
monitored by Performance Improvement
Department, there should be ongoing
efforts with Stroke Team and Performance
Improvement to improve stroke care by
utilizing benchmarking and performance
measures data
Educational Programs

In order to keep up with new developments
in stroke care, the stroke team professional
staff is required to maintain 8 hours CME (or
its equivalent) credits per year. In addition
to this, the stroke center should be able to
offer education to the community at least
twice a year in relation to Stroke recognition,
prevention, and treatment.
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Case Report: Vascular

Endovascular Cure
of a “Locked-In” Patient
Meryl A. Severson, III, MD, Aditya S. Pandey, MD, Erol Veznedaroglu, MD
Jefferson Hospital for Neuroscience, Philadelphia, PA

We report the case of a 60 year-old right-handed
gentleman who became acutely “Locked-In”
several days after a lower extremity orthopedic
procedure. He underwent emergent endovascular
treatment and had complete resolution of his
neurologic findings except for mild dysarthria
and dysphagia. Endovascular intervention
for posterior circulation thrombosis is highly
effective when patients are treated within
24 hours.

Case

Figure 1. Non-contrast computed

tomography scan of the head showing a
hyperdense basilar artery (arrow).

FC is a 60 year-old right-handed gentleman that
underwent uncomplicated total knee arthroplasty
and was started on low dose warfarin therapy
for deep venous thrombosis prophylaxis. On
postoperative day number two the patient
had an acute change in his neurologic status.
A computed-tomography scan of his head was
obtained showing a hyperdense basilar artery. He
was emergently transferred to our institution.

Figure 2. Digital subtraction

angiography AP projection of a selective
right vertebral injection showing
complete obstruction of flow at the
right vertebrobasilar junction.

On arrival the patient was lethargic but able to
follow commands with eye blinks only. His pupils
were equal and reactive but he only had vertical
gaze. The right extremity minimally withdrew to stimulation. Computed-tomography angiogram of
the head showed a dominant right vertebral artery with occlusion just distal to the posterior inferior
cerebellar artery origin extending to just below the superior cerebellar arteries.
The patient was taken emergently to the Endovascular Neurosurgery Suite and the right femoral artery
accessed. The right vertebral artery was selectively catheterized and digital subtraction angiography
performed revealing complete occlusion of the right vertebrobasilar junction without distal runoff
or PCA filling. A Hyperglide balloon was positioned at the VB junction and seven inflations were
performed, revealing a focal stenosis at the junction. A Gateway 4 balloon was positioned next and
inflated to six atmospheres of pressure. Subsequent angiographic runs revealed complete resolution
of the thrombus and filling of both PCAs and SCAs, as well as the basilar perforators. A Wingspan
4x5x20 stent was then deployed at the location of the stenosis resulting in complete resolution of
the stenosis and thrombus. Additional angiographic runs showed distal occlusions bilaterally in the
P4 segments; these were treated by placing an SL-10 microcatheter in the P4 segments and injecting
150,000 units of Urokinase on the right and 200,000 units on the left.
Post-procedurally the patient remained intubated for less than twenty-four hours. His neurologic
exam improved to normal except for mild dysarthria and dysphagia and a right upper extremity
drift without associated weakness. Magnetic resonance imaging of his brain revealed acute infarcts
in the left pons, right occipital lobe, right dentate nucleus, both mesial temporal lobes, and the
right posterolateral thalamus. He was gradually mobilized with the assistance of physical therapy/
occupational therapy and eventually discharged in good condition.

Figure 3. Digital subtraction

angiography AP projection
demonstrating inflation of the Hyperglide
balloon at the right vertebrobasilar
junction. Note the microcatheter
extending into the proximal basilar artery
and the “waist” (arrow) on the balloon
reflecting the location of the obstruction.

Discussion
Unlike anterior circulation thromboses,
the time window for posterior circulation
thrombosis treatment extends up to 24 hours
after the ictus. Cases of complete improvement
in an adolescent treated 20 hours1 and a child
almost 50 hours after symptom onset2 are
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Figure 4. Digital subtraction

angiography LAT projection of a right
vertebral injection after Hyperglide
balloon inflation. Note the improved
filling of the basilar artery. A Gateway
balloon has been advanced to the
vertebrobasilar junction.
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reported. However, we recommend treating up
to 24 hours post-ictus only. An additional study
reviewed outcome predictors for basilar artery
thrombosis and found that recanalization
after thrombolysis and low NIH stroke scale
at admission were associated with a favorable
outcome; initiating thrombolysis early after
ictus as well CT evidence of a hyperdense
basilar artery were positively associated with
recanalization rates.3 “Locked-In” Syndrome
resulting from acute basilar artery thrombosis
is curable but requires the patient be quickly
diagnosed and transferred expeditiously to a
specialized center with a highly experienced
endovascular neurosurgical team.
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Abstract
Summary of Background Data: Five cases of hemorrhage into a spinal neoplasm after spinal or
epidural anesthesia are reported in the literature. Presentation ranges from severe low back pain to
acute cauda equina syndrome.
Methods: A case study of a patient who hemorrhaged into an intradural, extramedullary spinal cord
mass was performed. A detailed literature review is also provided.
Results: A 27 year old female underwent epidural anesthesia for Cesarean section delivery. She
presented with a 3 week history of increasing low back pain with bilateral radiculopathy. Imaging
studies revealed a large hemorrhagic intradural mass compressing the lower conus medullaris and
cauda equina, which operatively was confirmed to be a myxopapillary ependymoma.
Conclusions: We report a case of hemorrhage into a previously unrecognized ependymoma
after epidural anesthesia. Underlying tumors may rarely complicate regional anesthesia in the
lumbar spine.
Keywords
Ependymoma, epidural anesthesia, spinal anesthesia, hemorrhage, myxopapillary ependymoma.
Abbreviation list
MRI: Magnetic resonance imaging

Introduction
Epidural anesthesia is a procedure which is well tolerated and has a low incidence of adverse events.
In performing caesarean sections, regional anesthesia (spinal or epidural) is the preferred modality
for anesthetic delivery7. Although rare with continuous epidural anesthesia, epidural hematomas
have been reported to occur with an incidence between 1:150,000 and 1:190,00010. An underlying
bleeding diathesis has been implicated as a causative factor. We present the sixth reported case of
hemorrhage into an occult intradural neoplasm after spinal or epidural anesthesia. Similar lesions
have not been reported in the recent spine literature.1, 2, 3, 5, 8

Case Report
A 27-year-old gravida 1, para 0 patient underwent a Caesarean section with epidural anesthesia
without difficulty. She was discharged home with a healthy infant on post operative day two. Three
days after the procedure the patient noted a moderate degree of low back pain, which was initially
attributed to ligamentous strain. Conservatively therapy, consisting of bed rest and analgesics,
failed to provide symptomatic relief. The symptoms persisted and the patient progressed over
the following three weeks, noting worsening low back pain radiating to the legs. The patient then
presented to the emergency department, where she described severe low back pain radiating
into both lower extremities. Her past medical history was insignificant. She denied any history
of coagulopathy, heavy menses or any contributory family history. A thorough neurological
exam revealed intact motor strength sensation, with normal deep tendon reflexes and an absent
Babinski’s sign. A rectal exam revealed normal anal sphincter tone and volition.

Figure 1. Sagittal T1 Lumbar Spine

MR Imaging post gadolinium reveals an
enhancing mass at the T12 - L1 spinal
levels with heterogeneous but intense
enhancement of the lesion and an
irregular central foci of nonenhancement.
The lesion fills the spinal canal, and
appears to arise from the terminal
portion of the spinal cord.

Investigations
No hematological abnormalities were noted
on laboratory examination. MR Imaging of
the lumbar spine with and without gadolinium
revealed an oblong intradural mass at T12-L1
with intense peripheral enhancement and
irregular central nonenhancement was noted
(Figures 1-3). Complete MR imaging of the
neuroaxis showed no additional lesions.
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Figure 2. Sagittal T2 Lumbar Spine

MR Imaging reveals an oblong intradural
mass 6.1 x 1.9 x 1.7 cm in the craniocaudal, transverse, and anterioposterior
dimensions. Bright imaging CSF appears
above and below the lesion. Again, the
lesion appears to begin at the terminal
portion of the spinal cord.
Treatment
The patient underwent a T12 to L2
laminectomy. Intraoperatively, an intradural
mass adherent to the cauda equina and
filum terminale with some intratumoral
hemorrhage was removed. A gross total
resection was accomplished.
Pathology
Finalpathologicanalysisofthesurgicalspecimen
revealed a myxopapillary ependymoma.
Postoperative Course
The patient made a full recovery. She
manifested initial urinary retention, which
resolved with the discontinuation of narcotics.
Postoperative MR Imaging revealed no
evidence of residual tumor.

Discussion
Extramedullary spinal cord tumors may be
intradural, extradural, or a combination of the
two. Extradural tumors account for roughly
30% of spinal cord neoplasms while intradural
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Figure 3. Axial T1 MRI lumbar spine MR Imaging post gadolinium at the level of L1
showing the intradural mass. The entire spinal canal is occupied by the heterogeneously
contrast enhancing mass.

extramedullary tumors are responsible for
approximately 40 to 50%.4 Intradural spinal
cord tumors are uncommon with an incidence
of about 3–10 per 100,000 individuals. These
tumors occur predominately in the third and
fourth decades of life.9 The most common
extramedullary spinal cord tumors are nerve
sheath tumors, meningiomas and filum
terminale ependymomas. Ependymomas
are the most common gliomas of the
lower cord, conus and filum terminale; the
myxopapillary histological variant is most
common. Approximately 40% of all spinal
ependymomas arise within the proximal
intradural filum terminale.4 Back pain is the
most common presenting symptom, with
neurological compromise rare secondary
to the adaptive compressibility of the
surrounding structures. Mork and Loken
report that in 82% of patients with spinal
ependymoma, symptoms were present for
more than 1 year before the diagnosis was
achieved.6 Treatment for these lesions is
typically en bloc surgical resection.9 Radiation
therapy is reserved for recurrent disease
or aggressive histopathology, with regular
radiographic follow-up recommended. In
cases of subtotal resection, radiotherapy may
be required.

Epidural anesthesia is an effective procedure
with a low incidence of complications.
Neurological compromise following epidural
anesthesia, while highly uncommon, is the
most concerning potential sequela of the
procedure. Epidural hematomas may rarely
occur during continuous epidural anesthesia,
with a reported incidence between 1:150,000
and 1:190,000.10 The majority of these cases
are believed due to a primary coagulopathy.
Rarely, hemorrhage from an occult spinal
mass occurs in an asymptomatic patient
receiving epidural anesthesia. The first case
of intratumoral bleeding in an asymptomatic
patient after attempted epidural anesthesia
was reported in 1984. A patient developed low
back pain, bladder dysfunction, worsening
motor and sensory function in both legs three
days after epidural analgesia.8 Since then,
four additional cases involving hemorrhage
into an occult neoplasm by regional lumbar
spine anesthesia have been reported. Three
cases involve epidural anesthesia 1,3,5 and
one was caused by a subarachnoid injection
of anesthetic.2 In each of these cases, the
underlying lesion was an ependymoma. In our
case and one other the only complaint prior
to neurosurgical intervention was severe low
back pain with increasing bilateral radicular
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Table 1. Reports of Hemorrhage into a Neoplasm After Regional Spinal Anesthesia
Author

Year

Patient

Antoniadis et al.
1985
79, female
				
1

Surgery

Anesthesia

Removal of femoral
osteosynthesis

Epidural

Tumor

Ependymoma

Bredtmann et al.2

1989

58, male		

Subarachnoid

Ependymoma

Jaeger et al.3

2002

28, female

Cesarian section

Subarachnoid

Ependymoma

Martin et al.5

1992

31, female

Cesarian section

Epidural

Ependymoma

Roscoe et al.8

1984

24, female

Cesarian section

Epidural

Ependymoma

pain.5 In the remaining reports, a component
of lower extremity weakness and bowel or
bladder dysfunction was noted. More severe
presentations are reported: Jaeger et al. detailed
a similar case with a lesion in a comparable area
and described neurological deficits progressing
to paraplegia within 24 hours.3 Previously
reported cases are reviewed in Table 1.

Conclusion
Occult spinal masses should be considered
in the differential diagnosis in a patient with
new onset neurological deficits or unusual
pain complaints after spinal or epidural anesthesia. MR imaging of the lower thoracic and
lumbar spine may be useful in evaluation of
these symptoms.
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Case Report: Signal Drop
on MRA Imaging of the Internal Carotid
Artery after Neuroform Stent Placement
Aditya S. Pandey, MD, Meryl Severson, MD, Robert Rosenwasser, MD
Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, PA

Introduction
Magnetic resonance angiography (MRA) is an important tool in evaluating the patency of vessels
which have previously been stented. Neuroform stents (Boston Scientific, Natick, MA, U.S.A.) are
utilized to provide a scaffold across the neck of an aneurysm. These stents are synthesized from
Nitinol (nickel and titanium) and thus cause minimal distortion upon imaging with MRA. Patients
who have undergone Neuroform stent assisted coiling of aneurysms are routinely followed with
MRA to delineate stenosis of the stented segment of vessel as well as recurrence of the aneurysms.
While numerous reports show that Neuroform stents do not lead to MRA imaging artifact, we report
of a case where the utilization of the Neuroform stent led to a signal drop out at the site of the stent
upon evaluation with MRA and thus led to further invasive radiological procedures.

Materials and Methods
This study is a case report identifying Magnetic resonance imaging artifact associated with the use of
Neuroform stents. Data was collected from the patient’s chart, operative report, and imaging studies.

Case Report
The patient presented in this report is a 55 year old right handed female who underwent screening
MRA of the head due to a family history of subarachnoid hemorrhage. This revealed a 5 mm left
carotid wall aneurysm. Subsequently, cerebral angiography revealed a broad based 6 mm by 4 mm left
posterior carotid wall aneurysm (Figure 1). The angioarchitecture of the aneurysm made it necessary
to place a stent in order to prevent coil prolapse into the parent vessel.
Due to technical difficulty associated with the tortuousity of the vessel, a Neuroform-3 stent was
prematurely deployed into the lacerum portion of the left internal carotid artery (ICA). However,
another neuroform-3 stent was able to be placed across the neck of the posterior carotid wall
aneurysm. Postoperatively, the patient remained neurologically intact and was maintained on plavix
therapy to prevent thromboembolic events. We allowed the stent to adhere to the vessel over a period
of eight weeks at which time the patient underwent coil embolization of the aneurysm without any
complications (Figure 2).
Four weeks post coiling, the patient presented to the emergency room complaining of right sided
numbness and tingling. A computed tomographic (CT) scan of the head was unrevealing of any
pathology. An MRI/A of the neck and head was performed to delineate whether a carotid dissection with associated thromboembolic event was the causation for the patient’s symptoms (Figure
3). This revealed a change in the caliber of the left ICA at the level of the petrous carotid. While
certainly this could represent susceptibility artifact from the deployed stent, no such cases have
been reported in the English literature. Thus the above mentioned imaging results led to the patient
being admitted to the hospital and subsequent prophylactic anticoagulation. A CTA of the head
was performed to better understand the exact location and length of the dissected segment of
vessel (Figure 4). Due to the surrounding bone associated with the petrous carotid artery, the CTA
was not revealing in delineating whether the MRA findings represented artifact or actual vascular
dissection. Thus it was essential to perform cerebral angiography which revealed no evidence of
dissection or recurrence of the previously coiled aneurysm (Figure 5).

Discussion
Use of self expanding Nitinol stents has revolutionized the treatment of intracranial aneurysms as
well as intracranial atherosclerotic disease. MRI/A have been shown to be of great value in evaluating
restenosis of a treated vessel or recanalization of treated aneurysms where these stents have been
utilized. A multitude of reports in the English literature have revealed that MRI/A creates minimal
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Figure 1. Cerebral angiography: early

arterial phase. Anterior-Posterior (A) and
Lateral (B) projections revealing a left
posterior carotid wall aneurysm.
artifact when imaging vessels with these stents.
In fact, there are no reports of MRA associated
signal drop out from imaging of vessels which
have been stented with Neuroform stents.
Our case report exemplifies that MRA imaging
can indeed create a signal drop out at the site of
Neuroform stent placement thus creating a false
image of possible dissection of the vessel. Such
an artifact can lead to further treatments and
imaging which not only increase the cost burden
to society but also can increase the morbidity to
the patient. While we did perform a computed
tomographic angiography (CTA) of the head, it
was of no value as the artifact from the petrous
bone prevented a clear delineation of whether a
dissection existed or not.

Case Report: Vascular

Figure 2. Left ICA injection: early arterial phase. AP (A) and Lateral (B) projections post
Neuroform stent placement and coil embolization of the posterior carotid wall aneurysm.

Figure 3. Magnetic Resonance

Figure 4. Computed tomographic

angiography (CTA) of the head
revealing the left petrous ICA not well
visualized due to artifact created from
the petrous bone.

Angiography (MRA) of the head
revealing a left petro us carotid artery
dissection which was later proved to be
signal drop out from the presence of a
Neuroform stent.

Figure 5. Cerebral angiography: left

common carotid artery injection early
arterial phase. AP (A) and Lateral (B)
projections revealing no evidence of
carotid dissection at the site of Neuroform
stent placement.

Neuroform-3 stents can create MRI associated
artifact/signal drop out and such this should
be taken into account when imaging vessels
which house such stents. While MRA with
gadolinium or CTA head can better visualize
the pathology, cerebral angiography remains
the gold standard in evaluating vessels which
have undergone stenting.

JHN JOURNAL

19

Departmental Information
Thomas Jefferson University
Department of Neurosurgery
909 Walnut Street 2nd and 3rd Floors
Philadelphia, PA 19107
Telephone: 215-955-7000
www.Jefferson.edu/Neurosurgery

Faculty
Robert H. Rosenwasser, MD, FACS, FAHA
Professor and Chair
David W. Andrews, MD, FACS
Professor and Vice Chair
Deborah L. August, MD, MPH
William A. Buchheit, MD, FACS
Professor Emeritus & Former Chair
Stephen J. Dante, MD, FACS
Assistant Professor
James J. Evans, MD
Assistant Professor
Jon Glass, MD
Associate Professor of Neurology
and Neurological Surgery
James S Harrop, MD, FACS
Associate Professor
Larry A. Harshyne, Jr, PhD
Instructor
Kenneth M Liebman, MD, FACS
Assistant Professor
Jewell L. Osterholm, MD, FACS
Professor Emeritus and Former Chair
John K. Ratliff, MD, FACS
Associate Professor
Ashwini D. Sharan, MD
Assistant Professor
Elisabeth J. Van Bockstaele, PhD
Professor and Vice Chair for Research
Erol Veznedaroglu, MD, FACS
Associate Professor

20

JHN JOURNAL

Research

Department of Neurosurgery
Clinical Research Publications
In Peer-reviewed Journals:
January 2007 through June, 2008
• Asadi-Pooya, A.A., Sharan, A., Nei, M., Sperling, M.R.
Corpus callosotomy. Epilepsy and Behavior. In press, 2008
• Harrop, J.S., Jeyamohan, S., Sharan, A., Ratliff, J., Flanders,
A., Maltenfort, M., Falowski, S., Vaccaro, A. Acute
cervical facture or congenital spinal deformity? Journal of
Spinal Cord Medicine. 31(1): 83-87, 2008
• Veznedaroglu, E., Koebbe, C.J., Siddiqui, A., Rosenwasser,
R.H. Initial experience with bioactive cerecyte detachable
coils: impact on reducing recurrence rates. Neurosurgery.
64(4): 799-805, 2008
• Fayssoux, R.S., Tally, W., Sanfilippo, J.A., Stock, G., Ratliff,
J.K., Anderson, G., Hilibrand, A.S., Albert, T.J., Vaccaro,
A.R. Spinal injuries after falls from hunting tree stands.
Spine Journal. 8(3): 522-528, 2008
• Patel, A.A., Brodke, D.S., Pimenta, L., Bono, C.M.,
Hilibrand, A.S., Harrop, J.S., Riew, K.D., Youssef, J.A.,
Vaccarro, A.R. Revision strategies in lumbar total disc
arthoplasty. Spine. 33(11): 1276-1283, 2008
• Ortiz, R., Stefanski, M. Rosenwasser, R., Veznedaroglu,
E. Cigarette smoking as a risk factor for recurrence of
aneurysms treated by endosaccular occlusion. Journal of
Neurosurgery: Spine. 108(4):649-654, 2008
• Andrews, D.W. Currrent neurosurgical management of
brain metastases. Seminars in Oncology. 35(2):100-107, 2008
• Fassett, D.R., Harrop, J.S., Vaccaro, A.R. Evidence on
magnetic resonance imaging of Brown-Séquard spinal cord
injury suffered indirectly from a gunshot wound: Case
report. Journal of Neurosurgery: Spine. 8(3):286-287, 2008
• Chandrasekar, T., Sharan, A.D., Sperling, M.R.
Postoperative auras and the risk of recurrent seizures.
Epilepsy Research. 78(3-Feb):195-200, 2008

• Sperling, M.R., Nei, M., Zangaladze, A., Sharan, A.D.,
Mintzer, S.E., Skidmore, C., Evans, J.G., Schilling, C.A.,
Asadi-Pooya, A.A. Prognosis after late relapse following
epilepsy surgery. Epilepsy Research. 78(1):77-81, 2008
• Falowski, S., Celii, A., Sharan, A. Spinal Cord Stimulation:
An Update. Neurotherapeutics. 5(1):86-99, 2008
• Zangaladze, A., Sharan, A., Evans, J., Wyeth, D.H., Wyeth,
E.G., Tracy, J.I., Chervoneva, I., Sperling, M.R. The effectiveness of low-frequency stimulation for mapping cortical
function. Epilepsia. 49(3):481-487, 2008
• Lee, J.Y., Vaccaro, A.R., Schweitzer Jr., K.M., Lim, M.R.,
Baron, E.M., Rampersaud, R., OÌˆner, F.C., Hulbert, R.J.,
Hedlund, R., Fehlings, M.G., Arnold, P., Harrop, J., Bono,
C.M., Anderson, P.A., Patel, A., Anderson, D.G., Harris,
M.B. Assessment of injury to the thoracolumbar posterior
ligamentous complex in the setting of normal-appearing
plain radiography. Spine Journal. 7(4):422-427, 2007
• Fassett, D.R., Jeyamohan, S., Harrop, J. Asymptomatic
Cervical Stenosis: To Operate or Not?. Seminars in Spine
Surgery. 19(1):47-50, 2007
• Curry, J.M., Cognetti, D.M., Harrop, J., Boon, M.S.,
Spiegel, J.R. Cervical discitis and epidural abscess after
tonsillectomy. Laryngoscope. 117(12):2093-2096, 2007
• Dvorak, M.F., Fisher, C.G., Aarabi, B., Harris, M.B.,
Hurbert, R.J., Rampersaud, Y.R., Vaccaro, A., Harrop, J.S.,
Nockels, R.P., Madrazo, I.N., Schwartz, D., Kwon, B.K.,
Zhao, Y., Fehlings, M.G. Clinical outcomes of 90 isolated
unilateral facet fractures, subluxations, and dislocations
treated surgically and nonoperatively. Spine. 32(26):30073013, 2007
• O’Leary, O.F., Bechtholt, A.J., Crowley, J.J., Hill, T.E., Page,
M.E., Lucki, I. Depletion of serotonin and catecholamines
block the acute behavioral response to different classes
of antidepressant drugs in the mouse tail suspension test.
Psychopharmacology. 192(3):357-371, 2007
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• Pandey, A.S., Koebbe, C., Rosenwasser, R.H., Veznedaroglu,
E. Endovascular coil embolization of ruptured and unruptured posterior circulation aneurysms: Review of a 10-year
experience. Neurosurgery. 60(4):626-636, 2007
• Smith, H.E., Rynning, R.E., Okafor, C., Zaslavsky, J., Tracy,
J.I., Ratliff, J., Harrop, J., Albert, T., Hilibrand, A., Anderson,
G., Sharan, A., Brown, Z., Vaccaro, A.R. Evaluation of neurologic deficit without apparent cause: The importance of a
multidisciplinary approach. Journal of Spinal Cord Medicine.
30(5):507-517, 2007
• Chaudhry, S., Sharan, A., Ratliff, J., Harrop, J.S. Geriatric Spinal
Injury. Seminars in Spine Surgery. 19(4):229-234, 2007
• Campbell, P.G., Harrop, J.S. Incidence of fracture in adjacent
levels in patients treated with balloon kyphoplasty: a review of
the literature. Current Reviews in Musculoskeletal Medicine.
1:61-64, 2007
• Schweitzer Jr., K.M., Vaccaro, A.R., Harrop, J.S., Hurlbert,
J., Carrino, J.A., Rechtine, G.R., Schwartz, D.G., Alanay,
A., Sharma, D.K., Anderson, D.G., Lee, J.Y., Arnold, P.M.
Interrater reliability of identifying indicators of posterior
ligamentous complex disruption when plain films are
indeterminate in thoracolumbar injuries. Journal of
Orthopaedic Science. 12(5):437-442, 2007
• Vadera, S., Harrop, J.S., Sharan, A.D. Intrathecal granuloma
and intramedullary abscess associated with an intrathecal
morphine pump. Neuromodulation. 10(1):6-11, 2007
• Vadera, S., Ratliff, J., Brown, Z., Patel, A., Harrop, J.S., Sharan,
A., Vaccaro, A.R. Management of Cervical Facet Dislocations.
Seminars in Spine Surgery. 19(4):250-255, 2007
• Pandey, A., Rosenwasser, R.H., Veznedaroglu, E.
Management of distal anterior cerebral artery aneurysms:
A single institution retrospective analysis (1997-2005).
Neurosurgery. 61(5):909-916, 2007
• Musacchio, M., Patel, N., Bagan, B., Deutsch, H., Vaccaro,
A.R., Ratliff, J. Minimally invasive lumbar laminectomy via a
dual-tube technique: evaluation in a cadaver model. Surgical
Neurology. 67(4):348-352, 2007
• Fassett, D.R., Harrop, J.S., Maltenfort, M., Jeyamohan, S.B.,
Ratliff, J.D., Anderson, D.G., Hilibrand, A.S., Albert, T.J.,
Vaccaro, A.R., Sharan, A.D. Mortality rates in geriatric
patients with spinal cord injuries. Journal of Neurosurgery:
Spine. 7(3):277-281, 2007

• Showalter, T.N., Andrel, J., Andrews, D.W., Curran Jr., W.J.,
Daskalakis, C., Werner-Wasik, M. Multifocal Glioblastoma
Multiforme: Prognostic Factors and Patterns of Progression.
International Journal of Radiation Oncology Biology Physics.
69(3):820-824, 2007
• Patel, A.A., Vaccaro, A.R., Martyak, G.G., Harrop, J.S.,
Albert, T.J., Ludwig, S.C., Youssef, J.A., Gelb, D.E., Mathews,
H.H., Chapman, J.R., Chung, E.H., Grabowski, G., Kuklo,
T.R., Hilibrand, A.S., Anderson, D.G. Neurologic deficit
following percutaneous vertebral stabilization. Spine.
32(16):1728-1734, 2007
• Harrop, J.S., Hanna, A., Silva, M.T., Sharan, A. Neurological
manifestations of cervical spondylosis: An overview of
signs, symptoms, and pathophysiology. Neurosurgery. 60(1
SUPPL.):0-0, 2007
• Patel, N., Bagan, B., Vadera, S., Maltenfort, M.G., Deutsch,
H., Vaccaro, A.R., Harrop, J., Sharan, A., Ratliff, J.K. Obesity
and spine surgery: Relation to perioperative complications.
Journal of Neurosurgery: Spine. 6(4):291-297, 2007
• Ratliff, J., Anand, N., Vaccaro, A.R., Lim, M.R., Lee, J.Y.,
Arnold, P., Harrop, J.S., Rampersaud, R., Bono, C.M., Gahr,
R.H. Regional variability in use of a novel assessment of thoracolumbar spine fractures: United States versus international
surgeons. World Journal of Emergency Surgery. 2(1), 2007
• Patel, A.A., Vaccaro, A.R., Albert, T.J., Hilibrand, A.S., Harrop,
J.S., Anderson, D.G., Sharan, A., Whang, P.G., Poelstra, K.A.,
Arnold, P., Dimar, J., Madrazo, I., Hegde, S. The adoption of a
new classification system: Time-dependent variation in interobserver reliability of the thoracolumbar injury severity score classification system. Spine. 32(3):S14-S20, 2007
• Whang, P.G., Vaccaro, A.R., Poelstra, K.A., Patel, A.A.,
Anderson, D.G., Albert, T.J., Hilibrand, A.S., Harrop, J.S.,
Sharan, A.D., Ratliff, J.K., Hurlbert, R.J., Anderson, P., Aarabi,
B., Sekhon, L.H.S., Gahr, R., Carrino, J.A. The influence of
fracture mechanism and morphology on the reliability and
validity of two novel thoracolumbar injury classification
systems. Spine. 32(7):791-795, 2007
• Vaccaro, A.R., Hulbert, R.J., Patel, A.A., Fisher, C., Dvorak,
M., Lehman Jr., R.A., Anderson, P., Harrop, J., Oner, F.C.,
Arnold, P., Fehlings, M., Hedlund, R., Madrazo, I., Rechtine,
G., Aarabi, B., Shainline, M. The subaxial cervical spine injury
classification system: A novel approach to recognize the
importance of morphology, neurology, and integrity of the
disco-ligamentous complex. Spine. 32(21):2365-2374, 2007
• Yadla, S., Ratliff, J.K., Harrop, J.S. Whiplash: diagnosis,
treatment, and associated injuries. Current Reviews in
Musculoskeletal Medicine. 1:65-68, 2007
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Department of Neurosurgery
Clinical Research Ongoing Studies
• The Wingspan™ Stent System and Gateway™ PTA Balloon
Catheter, a humanitarian use device
• A single blind, randomized evaluation of dilute Betadine solution irrigation versus normal saline irrigation in the prevention of postoperative posterior instrumented spinal surgeries
• A multicenter retrospective study of the effectiveness, safety
and treatment characteristics of subcutaneous neurostimulation (SQS) in patients with chronic pain
• Radiographic evaluation of intersegmental correction of
cervical kyphosis with combined anterior interbody grafting
and posterior instrumented arthrodesis
• Factors predicting the need for a ventricular peritoneal shunt
(VPS) in patients with cerebellar hemorrhage
• Magnetic resonance analysis of postsurgical temporal lobectomy and correlation to seizure outcome
• Management of pericallosal artery aneurysms at Thomas
Jefferson University
• Cordis ENTERPRISE™ Vascular Reconstruction Device and
Delivery System: a humanitarian use device
• Changing impedances over time with spinal cord stimulation
systems
• Identifying abnormal neurocognitive circuits in intractable
epilepsy
• Neurological deterioration after spinal cord injury
• Magnetic resonance imaging of cervical spondolytic myelopathy: correlation between findings and outcome
• Incidence and outcome of patients with spinal fracture and
ankylosing spondylitis
• FlexiCore Intervertebral Disc versus circumferential lumbar
spinal fusion for the treatment of discogenic pain unresponsive to conservative treatment associated with degenerative
disc disease

• Magnetic resonance imaging of spinal cord injury: correlation
with clinical findings and outcome
• A prospective, multi-center, randomized controlled study to
compare the spinal sealant system as an adjunct to sutured
dural repair with standard of care methods during spinal
surgery
• Carotid revascularization endarterectomy versus stent trial
(CREST)
• In vitro pilot study to determine the capacity of glioma
cells and metastatic intracranial tumor cells to cross-prime
dendritic cells and induce a measurable anti-tumor cytotoxic
T cell response
• Retrospective chart review of fractionated stereotactic radiotherapy for the treatment of residual craniopharyngioma
• The use of expandable vs non-expandable cages in vertebral
body replacement surgery: a retrospective review of outcomes
at Jefferson
• Retrospective review of surgical complications of occipital
nerve stimulator systems
• Surgical anastomosis of the superficial temporal artery to the
middle cerebral artery (STA-MCA) when added to the best
medical therapy for carotid occlusion
• Humanitarian use device: Neuroform Microdelivery Stent
• Role of brain tissue oxygen monitoring in detection of cerebral vasospasm
• Determinants of Hunt Hess grade: a retrospective analysis of
the last 100 patients admitted with subarachnoid hemorrhage
• Perimesencephalic subarachnoid hemorrhage: the role of
repeated cerebral angiography
• prospective glioma patients archival database including
parallel clinical, radiographic, histopathological, and unsupervised microarray analyses
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• A prospective national study to molecularly and genetically
characterize human gliomas: the glioma molecular
diagnostic initiative (GMDI) a retrospective review of
the radiographic and prognostic qualities of anaplastic
astrocytoma subtypes
• The role of increased CSF production in clinical and radiologic vasospasm
• The use of fractionated stereotactic radiotherapy for the
treatment of optic nerve sheath meningiomas: a retrospective medical record review
• A randomized, clinical trial of unruptured brain arteriovenous malformations (ARUBA)
• Surgical treatment of pituitary tumor-transition from open
to endoscopic approach
• Overall experience of pituitary tumor patients at Thomas
Jefferson University
• Growth of the cranial base program-Otolaryngology/
Neurosurgery experience
• The relationship of pre-existing junctional c2-c3 fusion with
odontoid fracture
• A multi-center retrospective cervical facet fracture/subluxation study
• Assessment of intracranial aneurysm shape as an indicator
of rupture risk
• A pilot study comparing various electrode and program
settings using the Eon IPG
• A retrospective review of the correlation between increased
T2 weighted signal on cervical spine MRI to myelopathic
clinical signs
• A retrospective chart review of cases done at Thomas
Jefferson University: the failure rate in surgical treatment
with fixation of c1-c2 fracture
• A retrospective chart review of TJUH patients who obtained
epidural injections; looking at the post procedural complications
• A phase i/ii dose-ranging study to evaluate the safety, tolerability, and pharmacokinetics of BA-210 and the neurological status of patients after a single, extradural application
of Cethrin (BA-210) during surgery for acute thoracic and
cervical spinal cord injury
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• Micrus® Cerecyte™ registry: a registry to evaluate outcomes
at one year post-embolization with the Micrus® Cerecyte™
• A multicenter retrospective chart review, reviewing the
safety and efficacy of the enterprise stent in patients with
intracranial aneurysm
• Retrospective 5 year review of follow up angiogram on
patients with cerebral aneurysms post clipping
• A prospective, multicenter, randomize, study comparing the
use of Healos to autograft in a transforminal lumbar interbody fusion (TLIF) approach
• Use of discarded tissue from frontal and temporal
lobectomy
• A multicenter retrospective chart review, reviewing the
safety and efficacy of the enterprise stent in patients with
intracranial aneurysm
• A retrospective review of post-treatment hemorrhage rates
of patients with arterio-venous malformations
• A comprehensive retrospective review of anterior corpus
callosotomy outcomes at TJUH, a substudy of previously
reviewed cases
• Clinical outcome in closed head injury: a retrospective
review of patients that received transfusion (FFP) versus
patients who were not transfused
• Atlanto-occipital dislocation injuries (AOD): a retrospective
review of management and outcome
• A retrospective and prospective review of peri-operative
complications in patients undergoing spine surgery
• Outcome of patients with ruptured aneurysm who underwent endovascular coiling procedure and evacuation of
intracerebral clot
• A pilot research study of Coumadin versus Plavix for the
treatment of carotid and/or vertebral artery dissection
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